Buscar
-
Is combined cataract surgery associated with acute postoperative endophthalmitis? A nationwide study from 2005 to 2014
(Br J Ophthalmol. vol. 103, n° 4, pp. 534-538, 2019-04)Article de revue -
Acute endophthalmitis after intravitreal injections of corticosteroids or anti-vascular growth factor agents. A nationwide study in France from 2012 to 2015
(Acta Ophthalmologica, European Association for Vision and Eye Research (EVER) Congress, fr, Nice, 2018-12)Communication dans un congrès avec actes -
Incidence of acute postoperative endophthalmitis following macular surgery in France between 2006 and 2016
(Acta Ophthalmol. vol. 98, n° 3, pp. e333-e338, 2020)Article de revue -
The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration
(Survey of ophthalmology. vol. 64, n° 5, pp. 707-719, 2019-09)Article de revue -
Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France
(JAMA ophthalmology. vol. 136, n° 12, pp. 1352-1358, 2018-12-01)Article de revue -
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources
(BMC Ophthalmol. vol. 19, n° 1, pp. 206, 2019-10-16)Article de revueLibre acceso -
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
(BMC Ophthalmology. vol. 20, n° 1, pp. 294, 2020)Article de revueLibre acceso -
A novel tool to assess the quality of RWE to guide the management of retinal disease
(Acta Ophtalmologica, 2020-12-28)Article de revueLibre acceso -
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
(The British Journal of Ophthalmology. vol. 105, n° 11, 2021-10-21)Article de revueLibre acceso -
Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 258, n° 3, pp. 521-528, 2020)Article de revueLibre acceso